Though coronary artery disease (CAD) remains the first cause of morbidity and mortality in the United States (http://www.americanheart.org), screening for asymptomatic disease has been at the center of a vivid debate for a long time. Several councils and professional associations have endorsed screening for subclinical atherosclerosis in selected patients. The American Heart Association/American College of Cardiology1 and experts of the National Cholesterol Education Program III (NCEP-III)2 suggested that screening may provide incrementally useful information in subjects judged to be at intermediate risk by traditional risk factors. The European Society of Cardiology3 recently noted that CAC is a sensitive marker of atherosclerosis, and it should not be used as a marker for underlying coronary luminal stenosis. Rather it should be used as a tool to improve risk assessment in individual patients. This organization further acknowledged that the prognostic relevance of CAC has been demonstrated in several prospective studies, not only in asymptomatic individuals but also in patients undergoing coronary angiography. However, screening for CAC should be reserved to individuals at intermediate risk and in men older than 45 years and women older than 55 yeears.3 These opinions are based on the analysis of available data on imaging along with an analysis of the distribution of cardiovascular risk in the adult population of Western countries. In the United States, among individuals older than 20 years, 40% to 45% are classifiable at intermediate risk (6%-20% risk of hard cardiovascular events at 10 years), 30% to 35% at low risk, and 25% at high risk. Because the largest proportion of the population is in the intermediate risk group, this is the group that experiences the bulk of events and therefore is the most expensive group for society. The cost of caring for cardiovascular disease is calculated at ap proximately $300 billion in the United States per year (http://www.americanheart.org), and early detection of disease and effective management of risk should guarantee an improved outcome with a related cost reduction due to the reduction in advanced forms of disease. Nonetheless, there are substantial limitations to this axiom: patients' adherence to risk-reducing practices is discontinuous, and current medical therapies are incompletely effective to eradicate disease. Furthermore, there are substantial costs inherent in the insufficient societal awareness of risk and the missed opportunity to screen for risk at the primary office level.4 Lack of awareness of risk, leading to disease development, is certainly more costly than effective screening and preventive programs.
Proposed approach to the diagnosis of obstructive coronary artery disease (CAD) in symptomatic patients according to the pretest probability of disease and level of coronary calcification. Several publications showed that the probability of obstructive CAD increases significantly when the coronary artery calcium (CAC) score rises above 400. That is why this score was chosen as the threshold beyond which further testing could be warranted. EBCT indicates electron-beam computed tomography; EF, ejection fraction.
Proposed use of subclinical atherosclerosis imaging in asymptomatic subjects with a preliminary assessment of risk based on Framingham risk score categories. The choice of a coronary artery calcium (CAC) score of 100, a carotid wall thickness of 1 mm and any of the 2 measurements higher than the 75th percentile for age- and sex-matched individuals was based on publications demonstrating the prognostic relevance of these measures. A measure of atherosclerosis higher than the 75th percentile for age and sex defines a vascular age older than the biological age of the individual. EBCT indicates electron-beam computed tomography; EF, ejection fraction; IMT, intima-media thickness.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 4
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Evidence Summary and Review 3
All results at
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.